BICO News Feed

Discover the latest news from our business areas.

SCIENION celebrates the laying of the foundation stone for new headquarters in Berlin Adlershof

Share on facebook
Share on twitter
Share on linkedin

Berlin, Germany; April 13, 2022

Together with numerous guests from politics, economics and science, SCIENION GmbH today celebrated the laying of the foundation stone of its new headquarters in Berlin Adlershof. The building complex will be constructed on a space of over 3000m², enabling the company to bundle global activities from a site with sufficient space to pave the way for further growth.

 

One of the first congratulators at the ceremony was Dr. Gregor Gysi, a prominent member of the German Parliament. The new construction at Wagner-Régeny-Straße 15 is located in his electoral district of Berlin Treptow-Köpenick. In his welcoming address he noted: “SCIENION GmbH is an example of the success of the science location Wista in Adlershof. The company was founded here, has been growing steadily ever since and is now building its new company headquarters here.”

 

Guest speaker, State Secretary Michael Biel from Berlin’s Senate Department for Economics, Energy and Public Enterprises, was delighted about SCIENION’s successful development that led to this investment into the construction of its new headquarters. He said: “SCIENION is a prime example of a successful and innovative company founding in Berlin. The company, which has received the Berlin-Brandenburg Innovation Prize twice, impressively shows how science and business can inspire each other in Adlershof. It is a great pleasure to see that SCIENION has remained faithful to Adlershof as a place of the future and that we as the State of Berlin have also been able to make a contribution to the expansion of the site with the offers and advice from our business development department. I wish SCIENION continued success and look forward to innovative developments and products ‘Made in Berlin’.”

 

In further addresses, Dr. Kai Uwe Bindseil, Cluster Manager Healthcare Industries Berlin-Brandenburg and Dr. Viola Bronsema, Managing Director of Bio Deutschland e.V., addressed the regional and national significance of SCIENION’s development as well as the involvement into science and industry networks. Dr. Kai Uwe Bindseil emphasized: “The entrepreneur Holger Eickhoff stands like no other for the rise of the health capital Berlin. In 25 years, starting as a postdoc and then as a founder, he has built up a globally active world market leader with a strong team. I am pleased that SCIENION’s next growth step will also take place in Berlin.” Dr. Viola Bronsema said: “SCIENION shows how bio-based inventions can be developed with experienced engineering services for application. The company has been a member of BIO Deutschland for almost a decade and has been a valued partner in biotechnological research and industry for twice as long.”

 

SCIENION has been located at the Science & Technology Park in Berlin Adlershof since its foundation in 2001 and has chosen to remain in the precinct due to its excellent environment. Therefore, today’s laying of the foundation stone was for SCIENION’s founder and CEO, Dr. Holger Eickhoff, a very special event: “We are delighted and proud to expand our premises due to our corporate growth. For SCIENION, it was the best and future-oriented decision to initiate the construction of our new headquarters in Berlin Adlershof. I would like to thank all people involved in this process, last but not least our parent group BICO. We, and by that I mean our entire great SCIENION team, are really looking forward to moving into our new premises next year.”

 

About SCIENION’s new construction project in Berlin, Wagner-Régeny-Straße 15

In February 2020, SCIENION acquired the leasehold for the 3,037 m² state-owned property from urban development agent, WISTA.Plan GmbH, with the building permit granted in early November 2020. Plans encompass the construction of a four-storied building complex with laboratories, clean rooms, production facilities, storerooms, areas for services, administration, sales and marketing, as well as an underground car park. Construction is expected to be completed by the end of May 2023. SCIENION GmbH is the builder of the new complex which is designed by AJS architekturbüro jürgen schlake GmbH, an architectural office that remains responsible for further project management. Following an invitation to tender, Adolf Lupp GmbH + Co. KG was commissioned as the general contractor for the turnkey completion of the building. The company has already completed a number of large building projects in Berlin Adlershof. Ruß Ingenieure AG, also based locally, acts as subcontractor and is responsible for planning technical building equipment.

 

About SCIENION

Founded in 2001, SCIENION is a renowned specialist in ultra-low volume precision liquid handling in the pico-liter to micro-liter range, enabling applications from research to high-throughput production of assays in diagnostics and life sciences. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION is an ISO 9001:2015 certified complete solution provider offering a unique portfolio of automated precision dispensing systems, readers, consumables, assay development and contract manufacturing services. The company operates from two sites in Germany, Dortmund and Berlin, and has subsidiaries in Arizona, USA; Chichester, UK; and Cellenion in Lyon, France.

SCIENION is part of BICO, the leading bio convergence company in the world that provides technologies, products and services to create the future of health.

 

Contact
SCIENION GmbH
Volmerstraße 7b
D-12489 Berlin
Phone: +49 (0)30 – 6392 1700
support@scienion.com
www.scienion.com

PR Contact
Almut Gebhard
Phone +49 (0)30 – 6120 1081
Mobile +49 (0)174 3017754
Email scienion@almutgebhard.de

More news

June 27, 2022 | Cytena

CYTENA is officially the Innovator of the Year 2022

June 7, 2022 | Cytena

CYTENA enters long term OEM supply agreement with PAIA and launches the F.QUANT Titer high-throughput titer quantification assays for antibodies and Fc fusion proteins

June 6, 2022 | Cellink

Bioprinted Ear Successfully Transplanted into Patient

June 1, 2022 | Dispendix

ESHG & ISSCR 2022

June 1, 2022 | Scienion

SCIENION bestellt Frauke Hein als CEO

June 1, 2022 | Scienion

SCIENION Appoints Frauke Hein as CEO

May 30, 2022 | Dispendix

BICO Management Summit 2022

May 24, 2022 | Bico

Biosero, a Part of BICO Biosciences Is Awarded a New Patent for Laboratory Automation Scheduling Software

May 24, 2022 | Cellenion

Breakfast with Cellenion

May 16, 2022 | Bico

BICO joins The North American 3Rs Collaborative’s (NA3RsC) Microphysiological Systems (MPS) Initiative

May 12, 2022 | Bico

BICO Group Adds Senior IR Manager to Its Executive Management

May 11, 2022 | Dispendix

SLAS Europe 2022 – Dublin

May 6, 2022 | Cellenion

cellenONE Training & Workshop – June 2022

May 6, 2022 | Cellink

BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology

May 5, 2022 | Cellink

CELLINK Announces CTR Scientific as Exclusive Distributor in Mexico

May 3, 2022 | Cytena

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development

April 13, 2022 | Scienion

SCIENION GmbH feiert Grundsteinlegung für neue Unternehmenszentrale in Berlin Adlershof

March 3, 2022 | Cellenion

Cellenion Announces Opening of BICO’s First Single Cell Analysis Centre of Excellence